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a b s t r a c t
Parvoviruses encode a small number of ancillary proteins that differ substantially between genera.
Within the genus Protoparvovirus, minute virus of mice (MVM) encodes three isoforms of its ancillary
protein NS2, while human bocavirus 1 (HBoV1), in the genus Bocaparvovirus, encodes an NP1 protein
that is unrelated in primary sequence to MVM NS2. To search for functional overlap between NS2 and
NP1, we generated murine A9 cell populations that inducibly express HBoV1 NP1. These were used to
test whether NP1 expression could complement speciﬁc defects resulting from depletion of MVM NS2
isoforms. NP1 induction had little impact on cell viability or cell cycle progression in uninfected cells,
and was unable to complement late defects in MVM virion production associated with low NS2 levels.
However, NP1 did relocate to MVM replication centers, and supports both the normal expansion of these
foci and overcomes the early paralysis of DNA replication in NS2-null infections.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Viruses in the family Parvoviridae have a linear single-stranded
DNA genome of around 5 kb, with small self-priming hairpin telo-
meres. Their constrained size leads them to be genetically compact,
using from one to three transcriptional promoters and one or two
polyadenylation signals to coordinate expression from two genes
clusters; a nonstructural (NS or rep) gene that encodes the viral
replication initiator protein (NS1 or rep), and a structural (VP or cap)
gene that encodes two or more size variants of a single capsid protein.
In addition, all viruses encode a few small ancillary proteins with
disparate structures and functions, which are variably disposed
throughout the genome (reviewed in Agbandje-McKenna and
Kleinschmidt (2011), Berns and Parrish (2013), Cotmore and
Tattersall (2013), and Halder et al. (2012)). These ancillary species
are typically conserved between viruses within each genus, but are
widely divergent between genera as illustrated for minute virus of
mice (MVM), a member of genus Protoparvovirus, and for human
bocavirus-1 (HBoV-1), from the genus Bocaparvovirus, in Fig. 1A and B
respectively. Genus names used throughout this paper reﬂect a recent
taxonomic revision in which parvoviruses that infect vertebrate hosts
and together constitute the subfamily Parvovirinae are now divided
between eight genera, all of which carry the inﬁx “parvo” in their
genus names, to clarify their family afﬁliation as discussed in Cotmore
et al. (2013), and posted online at: http://talk.ictvonline.org/ﬁles/
ictv_ofﬁcial_taxonomy_updates_since_the_8th_report/m/vertebrate-of
ﬁcial/4844.aspx (Taxonomy of the family Parvoviridae).
Due to their genetic minimalism, parvovirus DNA replication
mechanisms rely predominantly on the synthetic machinery of
their host cell, assisted and organized by the NS1 protein, while
the ancillary proteins fulﬁll multiple variable functions during the
viral life cycle, often serving, at least in part, to modulate the host
environment. In the current study we asked to what extent
replication defects that result from loss of the NS2 family of
ancillary factors encoded by MVM, can be complemented in trans
by expression of the very different HBoV1 NP1 protein. Viruses in
these two genera are relatively close phylogenetically, and share
the important characteristic of being heterotelomeric, meaning
that the hairpin telomeres at the two ends of the genome are very
different from each other. In MVM these disparate structures are
known to be processed by different mechanisms and at different
rates, adding a layer of complexity to the replication process that is
not seen for homotelomeric parvoviruses, such as those from the
Dependoparvovirus or Erythroparvovirus genera (Cotmore and
Tattersall, 2013). Nevertheless, the analogous terminal hairpin
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sequences of MVM and HBoV1 are very different from each other
(Huang et al., 2012), and this is mirrored by their widely disparate
ancillary proteins. While both NP1 and NS2 are known to be required
for the productive replication of their respective viruses (Chen et al.,
2010; Cotmore et al., 1997; Lederman et al., 1984; Naeger et al., 1990,
1993; Sukhu et al., 2013), they are encoded in different ways, and the
proteins show no apparent protein sequence similarity to each other
(Fig. 1C), have very different turn-over rates, and predominantly
occupy different cellular compartments.
As seen in Fig. 1A, MVM encodes twomajor forms of the 25 kDa
NS2 protein, called NS2P and NS2Y, generated by alternative splicing
at a small centrally-positioned intron, which differ only in their
extreme C-terminal hexapeptides (Morgan and Ward, 1986; Cotmore
and Tattersall, 1990). While NS2 proteins are typically dispensable for
productive viral replication in transformed human cell lines (Naeger
et al., 1990), they are absolutely required in cells of the virus's normal
murine host. These proteins all share a common N terminal domain
of 84 amino acids with NS1, but are then spliced into a different open
reading frame, as shown in Fig. 1A. NS2P and NS2Y “isoforms”
accumulate at a ratio of approximately 5:1 during infection, reﬂecting
the stoichiometry of splice donor and acceptor site usage at this
intron. NS2 isoforms are the most abundantly-expressed viral pro-
teins during the ﬁrst few hours after the cell enters S-phase (Ruiz et
al., 2006), but both forms are subject to rapid proteosomal degrada-
tion (Miller and Pintel, 2001), resulting in a half-life of around 1 h
(Cotmore and Tattersall, 1990).
Mutant viruses that fail to stably express NS2 show a severe defect
in viral DNA replication that restricts the accumulation of duplex
replicative-form (RF) DNA intermediates to 5% of wildtype levels.
While the role of the NS2Y isoform remains uncertain, since mutant
viruses that fail to express this species replicate like wildtype virus,
mutants that lack NS2P initiate infection efﬁciently in A9 cells but viral
DNA replication aborts early in the duplex ampliﬁcation phase. This
phenotype can be tracked by immunoﬂuorescence microscopy, where
it is seen to manifest between 6 and 12 h into S-phase as a profound
block to the normal progressive expansion of viral replication centers
(Ruiz et al., 2006), known as autonomous parvovirus-associated
replication (APAR) bodies (Cziepluch et al., 2000). However, these
structures apparently continue to sequester the same broad range of
cellular replication and DNA damage-response proteins that accumu-
late during the early stages of wildtype infection (Ruiz et al., 2011), and
even low level expression of NS2P can drive infected cells through the
block, suggesting that it involves a small number of NS2 targets or an
enzymatic process. In this paper we refer to the ability to overcome
this early duplex ampliﬁcation block as the “critical early function”
of NS2.
However, mutants that are able to express low levels of NS2P are
still severely impaired in their ability to expand through murine cells,
requiring progressively higher, doses of NS2 to maximize the produc-
tion of progeny virions. The roles played by NS2 in this late “progeny
function” are complex, since it is required for both efﬁcient capsid
assembly, which is a pre-requisite for virion production, and for early
virion release prior to cell lysis, which greatly enhances the rate at
which virus spreads between cells. During infection all NS2 species
appear predominantly cytoplasmic, in part due to interactions with
the nuclear export factor, Crm1, as illustrated by the fact that
leptomycin B, a Crm1 inhibitor, allows NS2 to accumulate in the
nucleus (Bodendorf et al., 1999). In vitro NS2 binds with high
“supraphysiological” afﬁnity to Crm1 (Bodendorf et al., 1999;
Engelsma et al., 2008; Ohshima et al., 1999), but mutations that
modify its Crm1-binding site (Miller and Pintel, 2002), or reduce it to
one of physiologically-normal afﬁnity (Eichwald et al., 2002; Engelsma
et al., 2008), substantially impair progeny virus production. This
implicates the NS2:Crm1 interaction in a late step(s) in virion
production or in their subsequent export, perhaps via assembly of a
tripartite (Crm1:NS2:virion) nuclear export complex, although such
Fig. 1. Comparison of the coding strategies and sequences of MVM NS2 and HBoV1 NP1 proteins. Panels A and B: The coding sequences of (A) MVM and (B) HBoV1 proteins
and positions of the viral promoters are aligned above line diagrams of the single-stranded viral genomes, which terminate in folded hairpin structures, shown expanded
20-fold in scale relative to the coding regions. Below these, NS protein-encoding transcripts are indicated by lines. These express blocks of protein sequence encoded in
separate reading frames, indicated by pale, medium and dark gray blocks. AAAAA¼polyadenylation sites. “NS2-F86am” marks the position of a termination codon
introduced into MVM that prevents stable expression of all NS2-encoding transcripts. Panel C: The protein sequence of NS2P aligned above that of NP1. Positions of actual
NS2 Crm1 and 14-3-3 binding sites and hypothetical NP1 binding sites for these proteins are shown boxed, together with the functional NP1 NLS sequence.
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complexes have proven difﬁcult to detect (Engelsma et al., 2008).
Phosphorylated NS2 forms also interact with two members of the
14-3-3 family of proteins, which may promote their cytoplasmic
retention, but this interaction is not essential for the MVM life cycle,
at least in culture, because its disruption has little affect on progeny
accumulation (Brockhaus et al., 1996; Nuesch, 2005). As indicated in
Fig. 1C, possible consensus binding sites for 14-3-3 and Crm1 proteins
are also present in NP1, but there is as yet no evidence that these sites
are functional. However, NP1 does have a potent classical bipartite
nuclear localization sequence (NLS) between residues 14 and 28,
which may be embedded within a broader non-classical NLS (residues
7–50; Li et al., 2013), and following both transfection and infection it is
reported to accumulate predominantly in the nucleus (Lederman et
al., 1984; Chen et al., 2010; Sukhu et al., 2013), suggesting that any
nuclear export motifs are conditional or of lesser afﬁnity.
As seen in Fig. 1B, HBoV1 encodes a single form of its 28 kDa
NP1 ancillary protein, from two similarly spliced mRNAs that are
transcribed from the single P6 promoter, but are differentially
polyadenylated at one of two possible sites. Transfection experi-
ments with mutant viral genomes suggest that the NP1 proteins of
both HBoV1 and minute virus of canines (MVC), a second Boca-
parvovirus, are required for efﬁcient replicative form (RF) DNA
ampliﬁcation in their respective cells (Huang et al., 2012; Sun et
al., 2009: Sukhu et al., 2013), perhaps recapitulating the “critical
early function” observed for NS2. Following transfection, RF
replication defects resulting from null mutations in MVC NP1
could be partially rescued by co-expression of its own NP1
sequence in trans, or that from either HBoV1 or the type species
of this genus, bovine parvovirus (BPV), which both show o47%
identity to the MVC protein (Allander et al., 2005; Sun et al., 2009),
indicating that the required activity is conserved between mem-
bers of substantially disparate viral species, infecting very different
host genera.
In addition, NS2 and NP1 both inﬂuence progeny virus produc-
tion by controlling the availability of precursor capsids, although
they achieve this in very different ways. Thus, during infection of
murine cells MVM NS2 is required for efﬁcient capsid accumula-
tion, at least in part because it inﬂuences the efﬁciency with which
VP precursors are assembled into particles (Cotmore et al., 1997),
while in MVC infections NP1 expression allows read-through of
the internal (proximal) polyadenylation site, which is required for
the accumulation of viral mRNAs encoding the capsid gene (Sukhu
et al., 2013). Although the mechanism controlling NP1-mediated
suppression of this site remains uncertain, it is of particular
interest because it represents the ﬁrst example of a parvoviral
ancillary protein being used to modulate RNA processing.
In the studies reported here we show that, despite the many
apparent disparities between NS2 and NP1, induced expression of
the HBoV1 NP1 protein in murine cells functionally complements
a major defect resulting from the loss of NS2.
Results
Development of an inducible (tet-On) A9 cell line expressing HBoV1 NP1
A non-clonal A9 cell population in which expression of the
HBoV1 NP1 protein could be induced by exposure to the tetra-
cycline analog doxycycline (Dox) was created by sequential infec-
tion with two lentivirus vectors. The ﬁrst allowed hygromycin
selection for expression of the tetracycline-dependent repressor/
transactivator mutant rtTA3 (pLenti-CMV-rtTA3-Hygro), creating
the A9rtTA3 cell population, while the second allowed bleomycin/
hygromycin double-selection for cells expressing the HBoV1 NP1
protein in the presence of Dox (pLV-tetO-NP1-Bleo), creating the
A9 /þNP1 population, as detailed in Materials and methods sec-
tion. When maintained in medium without Dox, rtTA3 binding to
tetO is very low and NP1 expression is barely detectable, but
Fig. 2. Construction and characterization of an inducible (tet-On) A9 cell line
expressing HBoV1 NP1 (A9/þNP1). Panel A: Kinetics of induction of NP1, as
estimated by Western blotting, in the A9/þNP1 cell line incubated with escalating
doses of Dox for 40 h. The left lane contains an extract of control A9rTA3 cells treated
with the highest dose of Dox. Panel B: Effect of increasing doses of Dox on the
cellular morphology of A9rTA3 and A9/þNP1 cell lines. Panel C: Cell viability of
A9rTA3 and A9 /þNP1 cell lines after treatment with different doses of Dox for 40 h.
Panel D: Typical changes in cell cycle proﬁle for A9rTA3 and A9/þNP1 cell lines
following exposure to Dox for 40 h.
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addition of Dox at different concentrations from 25 ng/ml to
200 ng/ml led to the progressive accumulation of NP1, as assessed
by Western analysis using a polyclonal rabbit serum speciﬁc for
NP1 amino acids 76–91 (Fig. 2A). In this ﬁgure, NP1 expression is
shown after induction for 40 h, since this was the maximum
period of sustained induction used in subsequent co-infection
experiments. NP1 accumulation was apparent after exposure to
the lowest Dox concentration (25 ng/ml), and showed an approxi-
mately linear response to drug concentrations up to 75 ng/ml, but
a sub-linear response at higher concentrations.
Physiological changes associated with HBoV1 NP1 expression
Induced cells were ﬁrst examined for signs of toxicity using
phase contrast microscopy. After 40 h A9 /þNP1 cells induced with
low doses of Dox (r50 ng/ml) were essentially indistinguishable
from un-induced cells, and while slight swelling and increased
rufﬂing was seen at higher doses, there was no overt toxicity
(Fig. 2B). Similarly, the percentage of dead cells, as assessed by
ﬂow cytometry using a Far red Live/Dead assay, was minimally
inﬂuenced by NP1 induction even at the highest doses of Dox,
(from 2.1% in the absence of induction, to 5.4% after exposure to
200 ng/ml Dox for 40 h), while at 50 ng/ml and below no sig-
niﬁcant differences were observed (Fig. 2C). Flow cytometry of
propidium iodide stained cells revealed that the cell cycle proﬁles
of uninduced A9rtTA3 and A9 /þNP1 cell populations were slightly
different (Fig. 2D), but within each population exposure to Dox
had only minor effects. Thus, in both cells types exposure to Dox at
200 ng/ml resulted in a slight reduction in the proportion of cells
in G1, which in A9 /þNP1 cells correlated with an increase in cells
at the G2/M boundary, but without any conspicuous effect on the
percentage of cells in S-phase.
We also looked for evidence of induced DNA damage responses
associated with NP1 expression. Infection with minute virus of
canines (MVC), from the genus Bocaparvovirus, is known to
activate the cellular Ataxia telangiectasia mutated (ATM) pathway,
and this has been shown to be essential for efﬁcient viral DNA
ampliﬁcation (Luo et al., 2011). However, such activation appears
to result from physical association of the Mre11-Rad50-Nbs1
(MRN) DNA damage sensor with replicating viral genomes, rather
than from expression of the viral proteins (Luo et al., 2013).
In accord with this observation, in the A9/þNP1 population
HBoV1 NP1 induction with the highest doses of Dox for 40 h
resulted in only slight (2-fold) increases in the accumulation of
phosphorylated H2AX (γH2AX) and activated Ser1981-pATM (data
not shown). Overall, we conclude that protracted incubation with
high doses of Dox has a slight but detectable effect on cell
physiology, but that exposure to 50 ng/ml results in substantial
NP1 induction without any signiﬁcant effects on cell viability or
cell cycle progression.
Time course of NP1 expression
We next explored NP1 expression with time following Dox
induction at 50 ng/ml. As shown in Fig. 3A, NP1 could be detected
by Western blotting after induction for 3 h, and began to plateau after
approximately 12 h. The immunoﬂuorescence staining analysis shown
in Fig. 3B revealed that 495% of these cells became rather uniformly
positive for nuclear NP1 by 24 h after the addition of Dox. In a second
assay, cells were incubated with Dox for 24 h and it was then
removed, and the remaining NP1 levels monitored with time over
the next 48 h (Fig. 3C). Under these conditions, NP1 levels remained
steady for the ﬁrst 8 h, but then declined, giving a half-life of between
8 and 16 h. In induced A9 /þNP1 cells this half-life reﬂects the kinetics
of repressor binding to the expression construct, together with the
combined stability of the protein and its mRNA. Overall, this indicates
that protein expression is stable for many hours following its induc-
tion, and suggests a protein half-life that is similar to the reported half-
life of 6–8 h for the MVC NP1 protein observed during infection of
WRD canine cells (Sukhu et al., 2013).
Since productive infection with MVM requires cells to enter
S-phase under their own cell cycle control, and we ultimately
intended to infect induced cell populations with this virus, we also
monitored cell cycle progression in A9/þNP1 cells with time after NP1
induction. Flow cytometry of propidium iodide stained cells (Fig. 3D)
showed that induction with 50 ng/ml of Dox for up to 12 h had no
detectable effect on cell cycle distribution, while sustained incubation
for an additional 12–28 h was associated with a limited reduction in
the proportion of cells entering S-phase, from around 25% to 18%,
and a coordinate increase in the proportion of cells in G2M, from
34% to 40%. Since MVM cell entry typically takes several hours
(Farr et al., 2006), we concluded that if cells were induced with 50 ng/
ml Dox at the time of MVM infection, NP1 expression should be well
Fig. 3. Time course of NP1 expression following addition of Dox at 50 ng/ml, and its
effect on cell cycle proﬁles of A9rTA3 and A9 /þNP1 cell lines. Panel A: Western blot
analysis of whole cell lysates from A9 /þNP1 cells at different times after NP1
induction. Panel B: Immunoﬂuorescence images showing the nuclear localization
of NP1 after induction with Dox at 50 ng/ml for 24 h. Panel C: Kinetics
of NP1 protein loss after removal of Dox. Panel D: Cell cycle proﬁles of A9rTA3
and A9 /þNP1 cell lines at different times after NP1 induction with 50 ng/ml Dox.
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established when infecting viruses reached the cell nucleus and
initiated infection, but that such cells should enter S-phase with
normal kinetics.
Relative NP1 and NS2 expression levels
When A9 /þNP1 cells were induced for 24 h with 50 ng/ml Dox
and examined by immunoﬂuorescence microscopy, the great
majority of cells showed evidence of nuclear NP1 expression,
although the intensity varied somewhat from cell-to-cell (data
not shown, re-examined in detail below). In order to estimate how
NP1 expression levels compared, on a molar basis, to NS2 levels
generated in such cells during infection, we created a CMV-driven
NP1–NS2 fusion construct, shown in Fig. 4A. Following transfec-
tion into the A9 /þNP1 population, cell extracts were prepared and
their protein content quantiﬁed prior to Western analysis. Accu-
mulation of the expressed 50 kDa fusion protein was detected
with rabbit antibodies directed against either NP1 or NS2 over a
range of extract concentrations, and compared using Image J (IJ)
software. Concentrations were then selected that gave staining
within a linear range for each antibody. As illustrated in Fig. 4B,
lane 4, when stained with the anti-NP1 antibody, 10 μg of one such
extract gave 21 arbitrary IJ units (or 2.1 units per μg protein), while
when stained with the NS2-speciﬁc antibody 1 or 2 μg of the same
extract (lanes 6 and 7) gave a fusion band of 8 and 16 IJ units
respectively (or 8 IJ units per μg protein). Thus staining of the
fusion protein with the NS2 antibody gave signals that were
approximately 4 stronger than those obtained using anti-NP1.
On the same membranes, NS2 levels induced in A9 cells 24 h
after infection with wildtype MVMp at an input multiplicity of
10,000 vg/cell were determined (lane 8), and the percentage of cells
infected at this multiplicity determined by indirect immunoﬂuores-
cence microscopy. When blots of these extracts were stained with
anti-NS2 (lane 8) 0.25 μg of extract gave 10 IJ units, but only 50% of
these cells showed evidence of NS expression by immunoﬂuores-
cence, meaning that 0.25 μg from a fully infected cell population
would be expected to yield 20 IJ units (or 80 IJ units per μg of
extract). In contrast, 0.5 μg of extract from A9 /þNP1 cells that had
been induced with 50 ng/ml Dox for 24 h (lane 3) stained with an
intensity of 19 IJ units using the anti-NP1 antibody. Based on these
values, and taking into account the 4 difference between the
staining intensity of the antibodies per microgram of target protein,
NP1 expression in 1 μg of the induced A9 /þNP1 extract (38 units)
would be equal to around 152 units of NS2 expression, which is
approximately twice the 80 units of NS2 that would be expected
from 1 μg of 100% MVMp infected cell extract. This suggests that
NP1 induction under these conditions is approximately equivalent
on a molar basis to twice the level of NS2 expression seen per
infected cell 24 h postinfection, and is likely to be within a
physiological range for NP1 expression during HBoV1 infection.
We use this level of Dox induction in all subsequent experiments.
Effects of NP1 induction on MVM replication centers
The cellular location of NP1 was monitored following Dox induc-
tion of uninfected A9 /þNP1 cells by immunoﬂuorescence microscopy.
As indicated previously, although staining intensities varied, NP1
expression was apparent in most cells, generally exhibiting a diffuse
nuclear distribution that was interrupted by a small number (2–4)
of more intense foci, as illustrated in Fig. 5A, top panel. These foci
typically co-localized with gaps in DAPI staining, suggesting that they
might correspond to nucleoli. This localization was conﬁrmed by
immunoﬂuorescent staining for ﬁbrillarin, a highly conserved protein
associated with small nucleolar RNAs (Westerndorf et al., 1998).
Nucleoli also showed punctate staining in these cells with
rabbit antibodies speciﬁc for the major nucleolar phosphoprotein,
nucleolin, which co-localized with ﬁbrillarin (Fig. 5A, lower panel).
Following infection with MVMp, NP1 and NS1 distribution in
induced A9 /þNP1 cells was then compared using anti-nucleolin
antibodies to identify nucleoli. It has previously been shown that
at around 6 h into S-phase, viral DNA replication ﬁrst becomes
apparent in distinct viral replication centers, called APAR bodies
(Cziepluch et al., 2000; Ruiz et al., 2006). As seen in Fig. 5B, in
A9 /þNP1 cells nucleoli, stained for nucleolin, were quite separate
from these NS1 containing APAR bodies, but during MVM infection
NP1 was progressively lost from many nucleoli and began instead
to colocalize with NS1 in APAR foci, as illustrated in Fig. 5C.
Progressive changes in MVM NS1 distribution in infected A9 cell
nuclei with time in S-phase have been described in detail (Ruiz et al.,
2011). That study identiﬁed a series of stages, designated I–IV, with
NS1 ﬁrst emerging as a large number of small faint speckles that were
spread throughout the nucleus but absent from nucleoli (class I). As
NS1 expression intensiﬁed, the protein appeared to accumulate,
staining more intensely in a limited number of (o10) larger foci
that occupied around half of the nuclear space (class II), and then
coalesced into 2–4 progressively larger foci (class III), before spreading
through the entire nucleoplasm (class IV). APAR bodies correspond to
classes II and III in this scheme, and are fairly short lived in wild type
infections, remaining as discrete foci for just a few hours (Ihalainen et
al., 2007, 2009). To monitor the progressive redistribution of NP1 with
time during infection, individual APAR foci in cells that were double
Fig. 4. Quantitative measurement of relative NP1 and NS2 expression levels. Panel A:
Schematic representation of the CMV-driven NP1–NS2–HA fusion construct. Panel B:
Western quantiﬁcation of NP1 accrual relative to total NS2 accumulation 24 h after
infection with wild type MVMp. Lanes 1 and 5 contain 10 μg of extract from
untransfected A9 cells. The quantity of test extract (in μg protein) is indicated above
each lane, in all cases adjusted to a total of 10 μg with extract from uninfected A9s, as
required. Lanes 2 and 3 contain extract (0.25 μg and 0.5 μg, respectively) from A9 /þNP1
cells after induction with 50 ng/ml of Dox for 24 h. Lanes 4, 6 and 7 contain extract (10,
1 and 2 μg, respectively) from uninduced A9/þNP1 cells that had been transfected with
the fusion construct described in panel A. Lane 8 contains 0.25 μg of extract from A9
cells infected with MVMp for 24 h as described in Material and method section. Lanes
1 to 4 were probed with a polyclonal antibody directed against NP1 residues 76–91, and
lanes 5 to 8 with a rabbit polyclonal antibody directed against the N-terminal 84 amino
acids of NS2. Image J (IJ) units are shown at the bottom of the ﬁgure. “fus”¼NP1:NS2:HA
fusion protein.
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positives for NS1 and NP1 expression were ranked according to their
APAR class, as illustrated by the higher-power micrographs shown in
Fig. 5D, and scored for the presence or absence of NP1, as detailed in
the histogram. This shows that at the ﬁrst time point (17 h postinfec-
tion), most class I foci and around 40% of class II foci lacked NP1, but
that as APAR bodies matured most of them became NP1 positive, and
this accumulation was even more apparent at later times postinfec-
tion. These observations suggest that NP1 forms speciﬁc interactions
that cause it to relocate to the sites of early viral DNA replication.
As shown in Fig. 5D and Fig. 6A upper panel, the smaller APAR
foci are typically short-lived in wildtype infections, and progress
rapidly to type IV. In contrast, in cells infected with the NS2-null
mutant F86am, they generally fail to progress beyond the class II
ampliﬁcation stage, as seen in the absence of Dox induction in
Fig. 6B, upper panel. The F86am mutant has a single amber
termination codon replacing the phenylalanine at residue 86 in
NS2, but rather than inducing premature termination of the
polypeptide, this nonsense mutation stops the detectable accu-
mulation of all NS2 species, likely because the splicing pattern
required to express the mutated central exon is suppressed, as
shown for some other NS2 nonsense mutants (Gersappe et al.,
1999). When used to infect A9 cells, F86am exhibits the severe
early defect in duplex DNA ampliﬁcation and the deﬁciency in
capsid assembly and accumulation discussed earlier (Cotmore et
al., 1997). However, as seen in Fig. 6B, lower panel, NP1 induction
was able to rescue the impaired maturation of APAR foci in many
of the F86am-infected cells, causing their NS1 expression proﬁles
to progress to classes III and IV. Quantifying this data, by classify-
ing and counting individual cells (Fig. 6C), revealed that the class
IV NS1-staining pattern was observed in o5% of uninduced
F86am-infected cells, but in 40% of cells following NP1 induc-
tion, which is close to the 50% involvement seen in control MVM
wildtype infections. Notably, as observed in the wildtype infection,
NS1 and NP1 effectively colocalized in classes II and III foci in the
F86am infections, placing NP1 in close proximity to the replicating
viral DNA. Overall, we conclude that NP1 expression in F86-am
NS2-null infections allows greatly enhanced APAR development,
which in a wildtype infection would normally be associated with
progressive duplex DNA ampliﬁcation.
HBoV1 NP1 partially complements replication defects in MVMp NS2-
mutants
We then used the NS2-null F86am mutant to ask if NP1-
induction can substitute for NS2 during early stages in infection.
To explore NP1 complementation under conditions of less extreme
NS2 deﬁciency we also used the mutants P-Yþ and PloY , which
allow limited accumulation of speciﬁc NS2 isoforms (Ruiz et al.,
2006). During wildtype MVMp infections, NS2P and NS2Y are
expressed at an approximately 5:1 ratio, but in the P-Yþ mutant
the major isoform fails to accumulate, and the minor form, NS2Y,
remains expressed at its normal levels. In contrast, with the PloY
mutant, NS2Y accumulation is lost and NS2p expression is
restricted by a mutation that impairs the efﬁciency of the large
NS2 splice.
Fig. 5. Nuclear and nucleolar localization of NP1. Panel A: After induction of A9/þNP1
cells with 50 ng/ml Dox for 24 h, NP1 shows a diffuse nuclear distribution, interrupted
by discrete foci that colocalize with ﬁbrillarin as detected by staining with mAb 72B9,
and thus correspond to nucleoli (upper panel). To conﬁrm this localization, mAb 72B9
staining is shown to colocalize with nucleolin in uninduced A9 /þNP1 cells (lower
panel). Panel B: The MVM nonstructural protein NS1 is speciﬁcally excluded from
nucleoli during infection. Panel C: Distribution of NP1 foci following infection with
wild type MVMp. During single round infections with MVMp, NP1 is relocated from
many, but not all, nucleoli, and progressively colocalizes with NS1 in developing MVM
replication foci, known as APAR bodies. Green arrowheads indicate NP1 still localized
in nucleoli, whereas yellow arrowheads indicate NP1 that has relocalized to APAR
bodies. Panel D: Histograms showing the percentages of NP1 negative and NP1
positive APAR bodies present 17 and 24 h after infectionwith MVM. At each time point
250 APAR bodies were scored both for NP1 and for their stage in APAR development,
from stages I to IV (examples of each stage are shown at the bottom of panel D).
Plotted data was from two independent experiments.
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In these experiments, we coordinately induced NP1 expression
in asynchronous populations of A9 /þNP1 cells with 50 ng/ml Dox
and infected the cultures with wildtype or mutant MVM particles
at an input multiplicity of 10,000 vg/cell. After allowing time for
viral penetration, neuraminidase-containing medium was added
to restrict infection to a single round, and cells were harvested
24 h postinfection. Western transfers (Fig. 7A) showed that infec-
tion with wildtype or mutant viruses had little, if any, effect on
NP1 accumulation and, as expected, NS2 was not detected in
infections with the NS2-F86am mutant. While NP1 induction did
result in a slight (10–20%) reduction in wildtype levels of NS1
and NS2 accumulation (Fig. 7A, lanes 3–4), it had no effect on the
more restricted NS2 accumulation seen for P-Yþ and PloY
mutants, and it marginally enhanced NS1 levels resulting from
all mutant infections. Probing with isoform-speciﬁc antibodies and
phosphoimager quantiﬁcation conﬁrmed that only NS2Y was
expressed in cells infected with the P-Yþ mutant, and that its
accumulation was substantially restricted relative to the total NS2
levels seen for wildtype virus, while infections with the PloY
mutant only supported NS2P expression, which accumulated to
around 10% of wildtype levels.
In the absence of NP1, capsid protein accumulation for F86-am
infections was limited to around 10% of wildtype levels, as
expected, while the progressive increases in NS2 expression seen
for the P-Yþ and PloY mutants were associated with increases
in capsid accumulation to 20–40% of wildtype levels. While sole
expression of NS2Y by the former mutant correlated with a small
increase in capsid protein accumulation (20% of wildtype),
expression of NS2P alone by the PloY mutant, even at much
lower copy number, resulted in slightly more effective capsid
protein accretion (o30%), indicating that on a molar basis the
NS2P isoform is substantially better able to promote capsid protein
production and/or accumulation. Nevertheless, VP accumulation in
all NS2 mutants was substantially impaired relative to wildtype,
and NP1 expression, which under the conditions used here should
result in NP1 accumulation to approximately twice the concentra-
tion of NS2 in the wildtype infection, had a negligible impact on
the defect. We conclude that the dosage-dependent role played by
NS2P in capsid protein accumulation cannot be complemented in
trans by NP1. Since capsid quantitation by Western analysis
measures both assembled and unassembled VP proteins, this
defect likely reﬂects their failure to assemble into particles, which
leads to poor VP accumulation since unassembled proteins turn-
over more rapidly than intact capsids (Cotmore et al., 1997).
In contrast, coincident expression of NP1 had a major affect on
the early duplex DNA ampliﬁcation block observed for the F86am
NS2-null mutant (Fig. 7B). In this case, RF accumulation in the
F86am infection was rescued to around 65% of the level seen with
wildtype virus in the absence of NP1. While RF accumulation was
also substantially (20%) enhanced in the wildtype infection by
NP1 induction, this may in part reﬂect a reduction in single-strand
encapsidation since progeny virion accumulation was impaired in
this group, as shown below (Fig. 7C). Similarly, NP1 expression
enhanced RF accumulation in all mutant infections, although on a
molar basis its effects were not as potent as those of NS2P, which
supported infection to 90% of wildtype levels when expressed at
just 10% of its normal concentration. Overall, this data provides
an explanation for the enhanced APAR maturation seen in the
presence of NP1, and shows that NP1 can efﬁciently complement
the early critical function performed by NS2. Thus, without having
any conspicuous sequence homology, elements in NP1 are func-
tionally homologous to NS2.
Progeny single-strand DNA production is difﬁcult to quantify
in neutral gels because it migrates as a broad diffuse band.
To overcome this problem we used a packaging assay in which
extracts were extensively nucleased to destroy non-encapsidated
DNA before the single-strands were released, and these were then
quantiﬁed as single bands following migration through denaturing
alkaline gels and Southern transfer. Using this approach, single-
strand accumulation in the cell pellet and medium were assessed
40 h after infection, with and without Dox addition (Fig. 7C).
Virion accumulation was extensive in both cells and medium from
wildtype infections, with the latter being predominantly due to
early virion release, since cell death remained limited at this time,
Fig. 6. NP1 expression rescues APAR body maturation in cells infected with an
F86am (NS2null) mutant of MVMp. Panel A: Patterns of NP1 expression and APAR
body maturation in A9 /þNP1 cells infected with wild type MVMp in the absence or
presence of Dox. Panel B: Patterns of APAR body maturation in A9 /þNP1 cells
infected with the F86am (NS2null) mutant. In the absence of NP1 expression
(upper panel), APAR maturation becomes progressively paralyzed at stages II or III.
Expression of NP1 partially rescues this phenotype, allowing progression to stage
IV (lower panel). Panel C: Histogram to quantify differences in APAR body
maturation following NP1 induction. Cells from infections shown in panels A and
B (1200 per infection) were scored for the developmental stage their APAR foci.
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as detailed below. In contrast, encapsidated DNA was rare in cells
and medium from F86am NS2-null infections, very slightly more
abundant in samples from P-Yþ infections, and present in
approximately NS2 dosage-dependent levels in the PloY infec-
tion. However, NP1 expression had a relatively minimal inﬂuence
of these levels. Thus for each mutant, virion production was
severely impaired relative to RF ampliﬁcation or even capsid
protein accumulation, but NP1 was unable to complement this
defect. Inefﬁcient capsid assembly, as likely occurs under these
conditions, typically leads to a deﬁciency of virion production
more profound than that predicted from VP protein accumulation,
as measured by Western blot, since only intact particles are able to
support packaging.
By 40 h postinfection 450% of the protected virion DNA
generated by wildtype infections had been released into the
medium both with and without NP1 (Fig. 7C). To ascertain the
extent to which this virus was released by directed transport
rather than cell lysis, we performed the capsid analysis shown in
Fig. 7D. This assay relied upon the fact that the trypsin used to
harvest infected cells also digested VP2 N-termini exposed at the
surface of full virions, but not empty particles, creating the VP3
form. Using small iodixanol step gradients and centrifugation
conditions designed to deliver both full and empty particles into
the ﬁrst (bottom) gradient fraction, we monitored virion and
empty particle accumulation by Western transfer using antibodies
directed against denatured capsids, scoring for the presence of VP2
versus the N-terminally proteolysed VP3 form. As shown in
Fig. 7D, upper panel, reconstructions using puriﬁed full and empty
particles showed that more than 90% of both types of particle
sedimented into the ﬁrst fraction, and could be readily identiﬁed
by the size of their predominant VP2/3 species. When used to
analyze medium from infected cells (Fig. 7D, lower panel), the
majority of particles from all samples contained predominantly
VP3, indicating that full virions were preferentially released from
these cultures and suggesting that cell lysis, which leads to the
release of both full and empty particles, was as yet negligible. This
analysis also conﬁrmed that capsid release from cells infected with
NS2 mutants was minimal compared to wildtype infections
(o5%), supporting the contention that overall VP accumulation
was impaired in all mutants, and recapitulating the virion DNA
disparity seen between these infections by Southern analysis
(Fig. 7C).
However, Fig. 7C also shows that approximately 50% of the total
virions were exported from all infected cells, irrespective of how
many virions were generated by each mutant. Thus the analyses
provide no evidence that the virion export mechanism is defective
in NS2 restricted infections, or that NP1 can inﬂuence this process.
Thus in the current experiments virion production, rather than
export, was most severely impacted by low NS2 levels. However, it
Fig. 7. Effects of NP1 expression on the course of A9/þNP1 infections with MVMp
wild type and NS2 dosage mutants. Panel A: Western blots showing the accumula-
tion of viral proteins after infection with wildtype and NS2-mutant MVMp viruses
in the presence or absence of Dox, as indicated above the blot. NS2-tot denotes all
forms of NS2; his indicates the position of histones, used as a loading control,
following detection with Ponceau Red. Panel B: Duplex intracellular replicative-
form (RF) viral DNA generated in single round infections in the absence or presence
of NP1 expression, analyzed by Southern transfer after electrophoresis through a
non-denaturing gel. Monomer (mRF) and dimer (dRF) duplex intermediates are
indicated. Panel C: Cell number-matched samples of nuclease-protected virion DNA
from cell pellets (upper panel) and culture medium (lower panel), analyzed by
Southern blotting after electrophoresis through denaturing gels. Panel D: Gradient
proﬁle analysis of viral particles released into the culture medium of A9 /þNP1 cells
infected with wildtype and NS2 mutant MVMp. In the upper panel a Western blot
shows VP species present in fractions 1–4 of analytical iodixanol step gradients
used to sediment trypsin-digested full virions and empty MVM capsids. Since
trypsin cleaves VP2–VP3 in full virions, but not in empty particles, this analysis
shows that both types of particles sediment into fraction 1 of the gradients. The
lower panel shows VP proteins recovered in fraction 1 of equivalent gradients used
to sediment particles recovered in the cell culture medium following trypsinization
of A9 /þNP1 cells infected with wildtype and mutant virions that had been cultured
in the presence or absence of Dox, as indicated. Mc and Mv denote empty and full
particles used as marker proteins.
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remains possible that so few virions are produced in the mutant
infections that they fail to overwhelm the cell's basal export
capacity, and so do not recapitulate the extensive requirement
for NS2:Crm1-mediated virion export discussed above.
Overall, we conclude that NP1 expression substantially rescues
NS2-null infections from a profound early DNA ampliﬁcation
block, but fails to complement later defects in capsid accumulation
and progeny virus production that result from inadequate levels
of NS2.
Discussion
In this paper we demonstrate that the HBoV1 NP1 protein can be
conditionally expressed in a non-clonal population of murine A9
cells without evoking major changes in cell cycle control or cell
death. Thus, although HBoV1 NP1 has been reported to induce
apoptosis following transfection into HeLa cells (Sun et al., 2013),
this is not observed in many other cell types (Sun et al., 2013; Chen
et al., 2010) or following NP1 induction in this study, and may reﬂect
a unique interaction with HeLa cells, perhaps involving their
transforming papilloma virus proteins (DeFilippis et al., 2003).
However, despite its conspicuous lack of homology with the
multifunctional MVM NS2 proteins, we show that inducible
expression of NP1 during infection with MVM NS2 mutants
effectively rescues an early and extreme defect in viral duplex
DNA ampliﬁcation associated with the NS2-null phenotype,
although it cannot substitute for NS2P in later, dosage-dependent,
role(s) played by this protein in progeny virion production.
Following its induced expression in A9 cells, NP1 predominantly
accumulates in the nucleus, adopting both a nucleoplasmic and
nucleolar distribution that has not been reported previously.
However, during infection with wildtype or NS2 mutant MVM,
NP1 is progressively withdrawn from most nucleoli and begins to
co-localize with NS1 in developing viral replication foci. How the
assembly of such foci is initiated, and how their many constituent
proteins are recruited remain poorly understood, but this translo-
cation would position NP1 in close proximity to the replicating
viral DNA. In NS2-null mutant infection this event coincides with
the ability of NP1 to rescue APAR body maturation from stage II to
stage IV foci and to substantially evade the shutdown of viral
replication. The molecular basis for this early block and how it is
subverted by NS2 remain to be determined, but the block occurs
soon after the initiation of viral DNA ampliﬁcation, at a time when
direct competition for cellular resources appears unlikely. This
timing suggests that it may well be a response to replicating
nuclear DNA, and that its induction should result in changes in the
way the infected cell responds to experimental stimuli, as recently
reported, for example, for IL-6 expression in response to poly I-C
stimulation (Mattei et al., 2013), or Chk1 activation in response
hydroxyurea treatment (Adeyemi and Pintel, 2014a). Overall,
plausible explanations include failure to evade aspects of the
induced DNA damage response (Adeyemi et al., 2010; Ruiz et al.,
2011), failure to subvert the cell cycle (Adeyemi and Pintel, 2014b;
Cotmore and Tattersall, 2013), or the induction of an innate
antiviral response to replicating viral DNA, which NS2P, and by
extension NP1, would be able to suppress. This latter mechanism is
supported by the ﬁnding that HBoV1 replicates in polarized
primary human airway epithelia (Huang et al., 2012; Deng et al.,
2013), which in vivo are highly exposed to inhaled respiratory
microbes and may be particularly well equipped to resist them.
In contrast, NP1 shows no evidence of complementing either of
the subsequent capsid accumulation or virion release defects that
perturb progeny virion production in the restricted low-NS2
phenotype. The high levels of NS2P required for efﬁcient capsid
assembly suggests that stoichiometric interactions between NS2
and either a cellular intermediary or the capsid precursors are
required. However, it is remarkable that capsid assembly is so
dependent upon NS2 during infection of A9 cells, since VP proteins
are readily assembled into particles without this ancillary protein
during infection of transformed human cells, or even when VP2 is
expressed on its own in insect cells. Possibly NS2, or a factor that it
recruits, is required to perform a chaperone-like function, as
demonstrated for the assembly-activating protein, AAP, encoded
by the related adeno-associated viruses (AAV). In AAV this protein
is located within the capsid gene, expressed from the same mRNA
as VP2, and targets VP proteins to the nucleoli, where it interacts
with their C-termini, inducing a conformational shift that appears
to promote particle assembly (Naumer et al., 2012; Sonntag et al.,
2010). A small alternatively translated (SAT) protein is encoded in
a similar position in the Protoparvovirus porcine parvovirus, and is
known to affect the rate at which infections spread through
culture (Zadori et al., 2005). However, SAT does not appear to be
directly homologous to AAP, and nonsense mutations inserted into
the equivalent sequence in MVM do not prevent capsid assembly
(our unpublished results), so that it is not clear how this sequence
functions.
Alternatively, NS2, or a factor that it recruits, may serve a critical
transport function that impinges on capsid assembly, removing
assembly inhibitors from the nucleus or promoting the inﬂux of
required factors that would otherwise by exported by cellular
mechanisms. Thus, the cellular export factor Crm1, which binds
NS2 with supraphysiological afﬁnity, might mediate such assembly
functions in addition to its proposed direct role in early virion export
(Eichwald et al., 2002; Miller and Pintel, 2002; Engelsma et al., 2008).
This interpretation is supported by in vivo selection studies in which
mutations in a region of NS2 that is immediately C-terminal to its
Crm1 binding site, further enhanced NS2:Crm1 interactions, leading
to conspicuous Crm1 accumulation in the cytoplasm and early and
enhanced virion production rather than speciﬁcally facilitated viral
egress from the cell (López-Bueno et al., 2004). When one such
mutation was introduced into an MVM genome that gave low NS2
accumulation levels when transfected into A9 cells, the mutation
allowed progeny single-strand DNA replication, which suggests that
it enhanced availability of competent capsids (Choi et al., 2005).
While not measured in this earlier study, the severe defect in capsid
accumulation seen in the present studies indicates that this is likely
to be the major late defect in NS2-low infections, and suggests that
high levels of nuclear Crm1 may constitute a dosage-dependent
block to particle assembly and accumulation. Preliminary studies
indicate that expression of high levels of NP1 in A9/þNP1 cells has
no conspicuous effect on the distribution of Crm1 (data not shown).
Further studies will be required to elucidate the mechanism under-
lying late defects in NS2-low infections, but the present studies
indicate that HBoV1 NP1 does not complement this aspect of the
complex phenotype exhibited by MVM mutants defective in the
expression of NS2.
Materials and methods
Constructs
pLV-tetO-NP1
Nucleic acids from a respiratory specimen positive for HBoV1 by
PCR were extracted with the QIAamp nucleic acid puriﬁcation kit
(Qiagen). The coding sequence for HBoV1 NP1 was ampliﬁed using
HotStarTaq DNA polymerase (Qiagen), with primers based on the
HBoV ST2 sequence (GenBank accession number DQ000496), and
cloned into the expression plasmid pcDNA3.1. The insert was
sequenced to conﬁrm that it corresponded exactly to ST2. This coding
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sequence was then used to replace the SOX2 gene in the EcoRI site of
Addgene plasmid 19765, pLV-tetO-SOX2 (Stadtfeld et al., 2008).
NP1–NS2p–HA fusion construct
First, a cDNA sequence encoding the MVMp NS2p protein with
a C-terminal HA-tag was generated using a PCR primer encoding
the HA-tag and Platinum Pfx DNA polymerase (Invitrogen). This
was cloned between the Hind III and Xba I sites in the pCDNA3.1
polylinker, generating an intermediate construct called pCDNA3
NS2p–HA. The coding sequence of HBoV1 NP1 was then ampliﬁed
using primers based on the HBoV ST2 sequence and cloned into
the Hind III site immediately upstream of NS2 in pCDNA3 NS2p–
HA, generating pCDNA3.1 NP1–NS2p–HA.
Cells and viruses
The prototype strain of MVM (MVMp, GenBank accession
number J02275) and its NS2 mutant derivatives F86-am, P-Yþ ,
and PloY (Ruiz et al., 2006) were propagated in the SV40-
transformed newborn human kidney cell line 324 K. Viral stocks
were puriﬁed by centrifugation through iodixanol (Optiprep, Axis-
Shield, Oslo, Norway) step gradients, as previously described
(D’Abramo et al., 2005) and quantiﬁed by Southern blot against
known amounts of genome-length viral DNA.
HEK293T cells maintained in Dulbecco's modiﬁed Eagle's medium
containing 10% fetal bovine serum and antibiotics were used for
packaging lentiviral particles as described at the Addgene web site:
http://www.addgene.org/tools/ protocols/plko/. Brieﬂy, lentiviruses
used to deliver the mutant tet-On (rtTA) version of the tetracycline
repressor were generated by cotransfecting 293T cells with Addgene
plasmid 26730: pLenti CMV rtTA3 Hygro (w785-1) (from Eric Cam-
peau, http://www.addgene.org/26730/) and a packaging system that
includes Addgene plasmid 12260: psPAX2 from Didier Trono (https://
www.addgene.org/12260), and Addgene plasmid 8454: pCMV-VSV-G
(Stewart et al., 2003), using X-tremeGENE 9 DNA transfection reagent
(Roche). Infectious particles containing pLV-tetO-NP1 were created
using the same packaging system. After 48 h, virus-containing super-
natants were removed, ﬁltered through a 0.45 μM PVDF ﬁlter (Milli-
pore), and lentiviral particles were concentrated using a Lenti-Xtm
Concentrator from Clontech, as described by the manufacturer.
The intermediate A9rtTA3 cell line is a multiclonal population of
murine A9 ouabr11 cells constitutively expressing the CMV-driven
rtTA3 regulatory protein (Markusic et al., 2005), generated by
infection with lentivirus particles carrying pLenti CMV rtTA3
Hygro, obtained from Addgene and selected in medium containing
0.5 mg/ml hygromycin. The A9 /þNP1 multiclonal cell line, capable
of inducibly expressing the HBoV1 NP1 protein under tetracycline
control, was created by infecting A9rtTA3 cells with a lentivirus
carrying pLV-tetO-NP1 Bleo, and selected with both 0.5 mg/ml
hygromycin and 80 mg/ml bleomycin. NP1 expression was induced
as required by adding the tetracycline analog doxycycline (Dox) to
the media.
NP1 expression and viral infection
A9rtTA3 or A9/þNP1 cells were seeded at 25% conﬂuence and
mock-induced or induced with Dox at the concentrations and for
the times indicated in the text. When indicated, virus infections
with wild type or NS2 mutant MVMp were initiated at the time of
Dox induction by addition of 10,000 viral genome equivalents per
cell (vge/cell) in DMEM containing 1% fetal bovine serum and
20 mM HEPES, plus or minus Dox, under single round of infection
conditions (Li et al., 2012). Brieﬂy, 4 h postinfection (pi) viral
inocula were removed, and the cultures incubated for 2 h with
fresh medium (þ/Dox) containing 0.04 units per ml of neur-
aminidase (Clostridium perfringens, type V; Sigma, St. Louis, MO)
to remove surface virus, after which the medium was replaced
with fresh neuraminidase-containing medium (þ/Dox) to pre-
vent subsequent re-entry of recycled virus. Cells were harvested
with trypsin 24 h pi, collected by centrifugation, and resuspended
in phosphate-buffered saline containing EDTA-free Complete pro-
tease inhibitor cocktail (Roche, Branchburg, NJ). Cells from each
plate were divided into aliquots to allow differential processing for
viral protein expression and DNA replication, as indicated below.
Western transfers
Cells were suspended in 1 lysis buffer (2% SDS, 10% glycerol,
62.5 mM Tris–HCI, pH 6.8, containing EDTA-free Complete protease
inhibitor and Phos STOP, phosphatase inhibitor cocktail (Roche), boiled
for 10 min and stored at 80 1C. Protein concentrations were deter-
mined using a Pierce BCA Protein Assay Kit (Thermo Scientiﬁc), and
20 mg aliquots (with added dyes and 100 mM DTT) were boiled for
10 min and loaded onto 4–20% Mini-Protean TGX gels (Bio-Rad).
Separated proteins were transfered electrophoretically to Immuno-
Blot polyvinylidene diﬂuoride membranes (Bio-Rad), stained with
Ponceau Red, and probed with rabbit polyclonal antibodies directed
against the following: 1) a peptide that corresponds to residues 76–91
from HBoV1 NP1; 2) the common N-terminal 84 amino acids shared
by MVM NS1 and NS2; 3) a peptide called “allo-p” that recapitulates
residues 311–327 in MVMp VP2. After incubation with horseradish
peroxidase-conjugated goat anti-rabbit IgG, bands were detected by
enhanced chemiluminescence using standard procedures.
Cell cycle distribution and detection of live and dead cells
A9rtTA3 or A9 /þNP1 cells were induced with Dox concentrations
between 0 and 200 ng/ml for 24 or 40 h, as indicated, recovered by
trypsinization and washed with cold PBS. For propridium iodide
staining, cells were ﬁxed by ethanol addition while vortexing,
pelleted, resuspended in PBS containing 0.5 mM EDTA and 1 mg/ml
heat inactivated RNAse A (American Bioanalytical) and incubated for
30 min at 37 1C. Propidium iodide (Sigma—P4170) was added to a
ﬁnal concentration of 0.05 mg/ml and samples were analyzed on
FACSCalibur (BD Biosciences). Cell death was also quantiﬁed by ﬂow
cytometry, using a LIVE/DEAD Fixable Far Red Dead Cell Staining Kit
(Invitrogen) according to the manufacturer's protocol and analyzed
by FACSCalibur.
Analysis of duplex viral DNA
Viral DNA was isolated as described previously (Cotmore and
Tattersall, 2011). Brieﬂy, cells were harvested with trypsin, resus-
pended in 10 mM Tris–HCI (pH 7.5) containing 10 mM NaCI and 4%
NP-40 and ﬂash frozen. These samples were later extracted by
mixing with an equal volume of 50 mM Tris–HCI; 20 mM EDTA; 2%
SDS at room temperature, and adjusted to ﬁnal buffer conditions
of 50 mM Tris–HCI; 15 mM EDTA; 0.5% SDS; 1% NP-40; 200 mM
NaCI before addition of proteinase K (to 250 μg/ml). Samples were
incubated at 45 1C for 2 h, 60 1C for 30 min, and gradual cooling to
room temperature overnight. DNA was isolated from aliquots of
these samples using a QIAquick PCR puriﬁcation kit (Qiagen) and
analyzed following electrophoresis through neutral agarose gel by
Southern transfer, quantiﬁed using a Typhoon Trio variable-mode
phosphorimager (GE Healthcare) with ImageQuant software.
Analysis of packaged viral DNA
For analysis of progeny virion DNA, both cells and medium were
harvested at 40 h pi following growth under single round infection
conditions. Brieﬂy, cells were harvested by trypsinization, recombined
with the culture medium, which was then pelleted by centrifugation,
allowing the clariﬁed medium and cells to be recovered and processed
separately. Cell pellets were resuspended in TE 8.7 (50 mM Tris–HCI,
0.5 mM EDTA, and pH 8.7), virus released by 3 cycles of freezing and
thawing, and the extracts clariﬁed by centrifugation. The resulting
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cell extract and cell-equivalent samples of culture medium were
then digested with micrococcal nuclease and proteinase K, and
analyzed on denaturing agarose gel as described previously (Farr
and Tattersall, 2004).
Recovery of trypsin digested viral particles from culture medium
As described in the previous section, cells were recovered by
trypsinization 40 h pi and added back into their culture medium. Cells
were then pelleted by centrifugation, and the supernate (4.5 ml)
underlayed with 0.5 ml of 15% iodixanol in TE 8.7, followed by
0.3 ml of 55% iodixanol in PBS containing 5 mm potassium chloride
and 1mmmagnesium chloride (PBSkm), to create two-step iodixanol
gradients. These were centrifuged at 35,000 rpm in a Beckman
SW50.1 rotor for 6 h, and 200 μl fractions collected from the bottom
of each tube. For test samples, 10 μl of fraction 1 from each group was
subjected to electrophoresis through a 10% polyacrylamide discontin-
uous SDS gel, transferred to PVDF membranes and probed with the
anti-allo-p antibody, which recognizes a linear sequence present in
both VP1 and VP2.
Immunoﬂuorescence microscopy. Assessing APAR bodies maturation
A9 /þNP1 cells seeded at 20% conﬂuence on Teﬂon coated spot-
slides were induced with Dox and/or infected with virus using the
single round infection conditions described previously. Cells were
ﬁxed with 2.5% paraformaldehyde at various times pi, as indicated,
permeabilized with 0.1% Triton X-100, and incubated with a murine
monclonal antibody (mAb) CE10 that recognizes NS1 (the kind gift
of Carol Astell; Yeung et al., 1991), an anti-ﬁbrillarin mAb 72B9 (the
kind gift of Susan Baserga; Westerndorf et al., 1998), polyclonal
rabbit antibodies to nucleolin (Antibody Verify), or rabbit antibodies
to HboV1 NP1 residues 76 to 91, followed by DyLight 594 Goat anti
mouse IgG or DyLight 488 Goat antirabbit IgG (BioLegend) and
DAPI. Images were acquired using standardized exposures on a
Zeiss Imager M2 AX10 epiﬂuorescence microscope ﬁtted with an
AxioCamMRm digital camera driven by AxioVision 4. 8. 1 software.
To assess APAR body maturation or to score NP1 redistribution to
APAR foci, 1000 cells from random camera shots were collected and
the nature of the APAR compartment assessed by counting against
published examples (Ruiz et al., 2011).
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